JessicaAnnHellyerMD

Oncology • Palo Alto, CA

Physician

Join to view full profile

Dr. Hellyer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Hellyer's full profile

Already have an account?

Office
875 Blake Wilbur Dr
Palo Alto, CA 94304
Is this information wrong?

Education & Training

University of Colorado School of Medicine Anschutz Medical CampusClass of 2014

Certifications & Licensure

WA State Medical License 2021 - 2026
PA State Medical License 2020 - 2022
CA State Medical License 2015 - 2021
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

2 citations
Predictive Model to Guide Brain Magnetic Resonance Imaging Surveillance in Patients With Metastatic Lung Cancer: Impact on Real-World Outcomes.
Julie Wu, Victoria Ding, Sophia Luo, Eunji Choi, Jessica Hellyer, Nathaniel Myall, Solomon Henry, Douglas Wood, Henning Stehr, Hanlee Ji, Seema Nagpal, Melanie Hayden ...> ;JCO Precision Oncology. 2022 Oct 1
5 citations
Autoimmune Disease in Patients With Advanced Thymic Epithelial Tumors.
Surbhi Singhal, Jessica Hellyer, Madhu M Ouseph, Heather A Wakelee, Sukhmani K Padda> ;JTO Clinical and Research Reports. 2022 May 1
5 citations
Consolidation Durvalumab Should Not Be Administered to Patients With Stage III EGFR-Mutant NSCLC.
Jacqueline V. Aredo, Jessica A. Hellyer, Joel W. Neal, Heather A. Wakelee> ;Journal of Thoracic Oncology. 2021 Dec 1
11 citations
Impact of Tumor Suppressor Gene Co-Mutations on Differential Response to EGFR TKI Therapy in EGFR L858R and Exon 19 Deletion Lung Cancer.
Jessica A. Hellyer, Maya N. White, Rebecca M. Gardner, Kristen M. Cunanan, Sukhmani K. Padda, Millie Das, Kavitha Ramchandran, Joel W. Neal, Heather A. Wakelee> ;Clinical Lung Cancer. 2021 Oct 21
36 citations
Genetic determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo
Giorgia Foggetti, Chuan Li, Hongchen Cai, Jessica A. Hellyer, Wen-Yang Lin, Deborah Ayeni, Katherine Hastings, Jungmin Choi, Anna Wurtz, Laura Andrejka, Dylan Maghini,...> ;Cancer Discovery. 2021 Jul 1
5 citations
Genomic clustering analysis identifies molecular subtypes of thymic epithelial tumors independent of World Health Organization histologic type.
Sukhmani K. Padda, Yesim Gökmen-Polar, Jessica A. Hellyer, Sunil Badve, Neeraj Kumar Singh, Sumanth Vasista, Kabya Basu, Ansu Kumar, Heather A. Wakelee> ;Oncotarget. 2021 Jun 8
64 citations
Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy.
Jacqueline V. Aredo, Isa Mambetsariev, Jessica A. Hellyer, Arya Amini, Joel W. Neal, Sukhmani K. Padda, Caroline E. McCoach, Jonathan W. Riess, Elwyn Cabebe, Jarushka ...> ;Journal of Thoracic Oncology. 2021 Jun 1
36 citations
Role of Consolidation Durvalumab in Patients With EGFR- and HER2-Mutant Unresectable Stage III NSCLC.
Jessica A. Hellyer, Jacqueline V. Aredo, Millie Das, Kavitha Ramchandran, Sukhmani K. Padda, Joel W. Neal, Heather A. Wakelee> ;Journal of Thoracic Oncology. 2021 May 1
23 citations
Clinical Implications of KEAP1-NFE2L2 Mutations in NSCLC.
Jessica A. Hellyer, Sukhmani K. Padda, Maximilian Diehn, Heather A. Wakelee> ;Journal of Thoracic Oncology. 2021 Mar 1
9 citations
Everolimus in the treatment of metastatic thymic epithelial tumors
Jessica A. Hellyer, Madhu M. Ouseph, Sukhmani K. Padda, Heather A. Wakelee> ;Lung Cancer. 2020 Nov 1
1 citations
Adjuvant Chemotherapy.
Jessica A Hellyer, Heather A Wakelee> ;Thoracic Surgery Clinics. 2020 May 1
62 citations
Role of KEAP1/NFE2L2 Mutations in the Chemotherapeutic Response of Patients with Non-Small Cell Lung Cancer.
Youngtae Jeong, Jessica A. Hellyer, Henning Stehr, Ngoc T. Hoang, Xiaomin Niu, Millie Das, Sukhmani K. Padda, Kavitha Ramchandran, Joel W. Neal, Heather A. Wakelee, Ma...> ;Clinical Cancer Research. 2020 Jan 1
9 citations
Phase II trial of single agent amrubicin in patients with previously treated advanced thymic malignancies.
Jessica A. Hellyer, Matthew A. Gubens, Kristen M. Cunanan, Sukhmani K. Padda, Matthew Burns, A. John Spittler, Jonathan W. Riess, Melanie San Pedro-Salcedo, Kavitha Ra...> ;Lung Cancer. 2019 Sep 18
11 citations
Sex disparities in lung cancer incidence: validation of a long-observed trend.
Jessica A. Hellyer, Manali I. Patel> ;Translational Lung Cancer Research. 2019 Aug 1
30 citations
Impact of KEAP1/NFE2L2/CUL3 mutations on duration of response to EGFR tyrosine kinase inhibitors in EGFR mutated non-small cell lung cancer
Jessica A. Hellyer, Henning Stehr, Millie Das, Sukhmani K. Padda, Kavitha Ramchandran, Joel W. Neal, Maximilian Diehn, Heather A. Wakelee> ;Lung Cancer. 2019 Aug 1
10 citations
Role of Immunotherapy in Small Cell Lung Cancer, Thymic Epithelial Tumors, and Mesothelioma
Christine L. Hann, Arnaud Scherpereel, Jessica A. Hellyer, Heather A. Wakelee> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2019 May 17
69 citations
Homologous recombination deficiency (HRD) status predicts response to standard neoadjuvant chemotherapy in patients with triple-negative or BRCA1/2 mutation-associated...
Melinda L. Telli, Jessica A. Hellyer, William Audeh, Kristin C. Jensen, Shikha Bose, Kirsten Timms, Alexander Gutin, Victor Abkevich, Rebecca N. Peterson, Chris Neff, ...> ;Breast Cancer Research and Treatment. 2018 Apr 1
Join now to see all